Dok-1 and Dok-2 play a cooperative role in protection against DSS-induced colitis.
Dok-1/-2 double KO (DKO) mice show extensive ulceration of the colon after DSS treatment.
Proliferation of colonic epithelium is inhibited in DSS-treated Dok-1/-2 DKO mice.
Expression of IL-17A and IL-22 is reduced in the colon of DSS-treated Dok-1/-2 DKO mice.